Blue-Zone Technologies Ltd. (“Blue-Zone”) is a Canadian-based cleantech pharmaceutical company that leverages globally patented technology to collect and process Waste Anesthetic Gases (WAGs) to provide a sustainable and cost-efficient source of inhalation anesthetic drugs, reducing environmental waste and lower costs for healthcare facilities.
Blue-Zone Technologies has gained recognition and attention for its innovative technology and was featured in the 7th SCI Innovation Competition. The competition showcased some of the brightest tech ventures from Canada, each on a mission to bring their cutting-edge products and services to the global market. Blue-Zone Technologies used this platform to showcase their innovative technology, which contributes to sustainable and environmentally friendly healthcare practices.
“We are thrilled to be selected as a global finalist in the 7th SCI Innovation Competition. This recognition is a testament to the hard work and dedication of the entire Blue-Zone Technologies team. We believe that our innovative technology has the potential to revolutionize healthcare practices and promote sustainable and eco-friendly solutions. We are excited to showcase our technology, and we look forward to collaborating with other industry leaders to create a healthier and more sustainable future for everyone.” – Kipton Lade, CEO of Blue-Zone Technologies.
The 7th SCI Innovation Competition brought together a distinguished panel of competition judges, including Dr. Reza Moridi, former Minister of Research and Innovation for the Province of Ontario, Benton Leong, Vice President of Investment at Lumira Ventures, and Dr. Zheng Hong (George) Zhu, Professor of Mechanical Engineering at York University. The panel also included Dr. Heyu Ni, Professor of Medicine at the University of Toronto, Stuart Browne, CEO of Pycap Venture Partners, Bruce W. Young, Managing Director at InnoCité, and Andre Tilban-Rios, Director of Investments at BDC Capital.
Their diverse backgrounds and expertise played a pivotal role in identifying the most promising ventures and ensuring that the competition remained at the forefront of technological innovation. In addition to the panel of competition judges, the event also featured keynote speakers who provided valuable insights into the world of business and the importance of global collaboration and market expansion.
Mark Miller, CEO of Volaris Group, spoke about the challenges and opportunities of scaling a business in a global marketplace, while Sarah Kutulakos, Executive Director & COO of Canada China Business Council, shared her experience in building cross-border partnerships and promoting trade between Canada and China. The keynote speakers provided valuable insights that complemented the competition’s focus on technological innovation and its impact on global markets.
The global competition will be held in Shenzhen, China on April 7 – 14, 2024.
About Blue-Zone Technologies Ltd.
Headquartered in Toronto, Ontario, Canada, Blue-Zone’s mission is to reduce hazardous environmental waste in healthcare facilities and lower financial costs by applying Blue-Zone’s patented technology. Blue-Zone collects unused anesthetics that would normally be vented into the environment and processes the collected material into its pure form providing a sustainable and cost-efficient source of inhalation anesthetic drugs. As such, Blue-Zone is the world’s first Cleantech Pharmaceutical Company, running a fully operational, GMP compliant, Health Canada licensed Drug Establishment Facility for Anesthetic Recovery, Raw Material and Final Product Production. For more information visit www.blue-zone.com.
